Comprehensive protein identification and intact protein analysis

Utilizing advanced mass spectrometry, this service identifies and characterizes proteins within complex biological samples, facilitating insights into protein functions and interactions

Disease biomarker discovery

By comparing protein expression profiles between healthy and diseased tissues, this service identifies potential biomarkers, aiding in early diagnosis and targeted therapy development.

Drug target identification and validation

Employing chemical proteomics and protein interaction analyses, this service identifies and validates protein targets for drug development, elucidating drug mechanisms and enhancing therapeutic efficacy.

Protein-Protein Interaction (PPI) studies

This service maps protein interaction networks using methods like co-immunoprecipitation and mass spectrometry, revealing cellular signaling pathways and potential therapeutic targets.

Analysis of post-translational modification (PTM) Analysis

Analyzing chemical modifications such as acetylation, phosphorylation and ubiquitylation, this service elucidates PTMs' roles in regulating protein function and their implications in diseases.

Comparative and quantitative proteomics

Utilizing techniques like label-free quantification and isobaric labeling, this service compares protein abundances across samples, providing insights into disease mechanisms and treatment responses.

Single Cell Proteomics

This service analyzes protein expression at the single-cell level, uncovering cellular heterogeneity and informing precision medicine approaches.

Structural Proteomics and Epitope Mapping

Combining crosslinking mass spectrometry and computational modeling, this service determines protein structures and maps antibody-binding sites, facilitating vaccine and therapeutic antibody development.

Immunopeptidomics

Profiling peptides presented by MHC molecules, this service identifies tumor-specific antigens, advancing cancer immunotherapy and vaccine development.